CAS: 835621-11-9 - 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, 1-oxide

Formula: C₂₁H₁₅ClF₄N₄O₄

Regorafénib N-oxyde (M2)

CAS: 835621-11-9

Regorafénib N-oxyde M2 is an active metabolite of Regorafenib.

• Formula: C₂₁H₁₅ClF₄N₄O₄
• Purity: 98.03% - 99.48%
• Color and Shape: Solid
• Molecular weight: 498.81

Regorafenib N-Oxide (M2 Metabolite)

CAS: 835621-11-9

• Formula: C₂₁H₁₅ClF₄N₄O₄
• Color and Shape: White To Off-White Solid
• Molecular weight: 498.82

Regorafenib N-Oxide-13C-d3 (M2 Metabolite-13C-d3)

CAS: 835621-11-9

• Formula: C₂₀₁₃CH₁₂D₃ClF₄N₄O₄
• Color and Shape: White To Off-White Solid
• Molecular weight: 502.83

Regorafénib N-oxyde M2

CAS: 835621-11-9

• Molecular weight: 498.82

Regorafenib (Pyridine)-N-oxide

CAS: 835621-11-9

Stability Light Sensitive Applications Regorafenib (Pyridine)-N-oxide is a synthetic metabolite of Regorafenib (R143000) and is …

• Formula: C₂₁H₁₅ClF₄N₄O₄
• Color and Shape: Neat
• Molecular weight: 498.81

Regorafenib metabolite M2 oxide

CAS: 835621-11-9

Regorafenib metabolite M2 oxide (M2O) is a cancer drug that is an inhibitor of multikinase. …

• Formula: C₂₁H₁₅ClF₄N₄O₄
• Purity: Min. 95%
• Molecular weight: 498.81 g/mol